Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00622778
Other study ID # 3-Wolf
Secondary ID
Status Completed
Phase N/A
First received February 13, 2008
Last updated April 10, 2012
Start date October 2007
Est. completion date July 2011

Study information

Verified date July 2011
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: Medical University of Vienna local Ethics Committee
Study type Observational

Clinical Trial Summary

The purpose of this study is to try to prove the worth of the two (2) Serum Proteins S-100 Beta and NSE in combination with a diagnostic algorithm to help to establish diagnosis in patients with minor head injury.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date July 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 1 Year and older
Eligibility Inclusion Criteria:

- minor head injury

Exclusion Criteria:

- severe head injury

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

References & Publications (3)

Pelinka LE, Bahrami S, Szalay L, Umar F, Redl H. Hemorrhagic shock induces an S 100 B increase associated with shock severity. Shock. 2003 May;19(5):422-6. — View Citation

Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma. 2004 Nov;21(11):1553-61. — View Citation

Pelinka LE, Toegel E, Mauritz W, Redl H. Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock. 2003 Mar;19(3):195-200. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Intracranial Haematoma 2 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03291964 - Rapid MRI for Acute Pediatric Head Trauma
Completed NCT02828306 - Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects
Completed NCT04505293 - Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas N/A
Not yet recruiting NCT02232347 - Ketamine and Glutamate After Brain Injury : a Microdialysis Study Phase 2
Completed NCT01448473 - Is a Two-Film Skull X-ray Series as Sensitive as a Four-Film Series in the Diagnosis of Skull Fractures in Paediatric Patients N/A
Terminated NCT00847977 - Interest of Using Balanced Fluid for Infusion at the Early Phase of an Acute Cranial Trauma for Limiting Hyperchloremic Acidosis Phase 3
Completed NCT04495634 - Evaluation of a Carbon Nanotube Enabled Solid-State Head CT N/A
Terminated NCT03680911 - NAC for Head Trauma-induced Anosmia Phase 3
Recruiting NCT06173427 - Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD
Completed NCT03742427 - Effect of Cervical Collar on the Optic Nerve Sheath Diameter in Minor Head Trauma N/A
Terminated NCT06246500 - Severe Head Trauma: Coagulation and CT-Scan Aggravation.
Withdrawn NCT03453749 - Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury Phase 2
Completed NCT00995683 - Preventive Sodium Lactate and Traumatic Brain Injury Phase 2/Phase 3
Not yet recruiting NCT05195606 - The Effect of Auditory and Tactile Stimuli in Traumatic Coma N/A
Completed NCT04020874 - Reducing Head Impact Exposure in Hawaii High School Football N/A
Not yet recruiting NCT06113939 - Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning N/A
Recruiting NCT05386966 - Medicolegal Aspects of Head Trauma
Not yet recruiting NCT03704272 - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral N/A
Active, not recruiting NCT00196131 - Problems With Morphine Use in Patients With a Severe Brain Injury Phase 1/Phase 2
Withdrawn NCT02798601 - Early Induced Hypernatremia for the Prevention and Management of Brain Edema N/A